WELBAS-LC is a targeted anti-allergic and dry-cough syrup combining cough suppression with antihistaminic activity. It is positioned for patients with non-productive cough accompanied by allergic manifestations, helping reduce cough frequency while addressing associated allergy symptoms. A differentiated PCD Pharma Anti-Allergy & Respiratory offering.
Dry cough associated with allergic symptoms.
Yes, due to Chlorpheniramine.
Avoid driving and alcohol if drowsy. Use according to the prescribed dose and inform the physician about other sedating medicines.
Drowsiness, dizziness, dry mouth, nausea and fatigue may occur.
WELBAS-LC: Levodropropizine acts peripherally to suppress the cough reflex, while Chlorpheniramine blocks H1 histamine receptors to reduce allergic symptoms.